Maral J. Rouhani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maral J. Rouhani has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Chadwan Al Yaghchi
Imperial College Healthcare NHS Trust
4 shared publications - Elizabeth F. Maughan
Charing Cross Hospital
3 shared publications Guri Sandhu
National Centre for Airway Reconstruction Charing Cross Hospital Imperial College Healthcare NHS Trust London UK
3 shared publicationsAnthony Rotman
Charing Cross Airway Service Department of Otolaryngology Charing Cross Hospital Imperial Healthcare NHS Trust London UK
2 shared publicationsChadwan Al Yaghchi
National Centre for Airway Reconstruction Charing Cross Hospital, Imperial College Healthcare NHS Trust London United Kingdom
2 shared publicationsGerard Thong
Charing Cross Airway Service Department of Otolaryngology Charing Cross Hospital Imperial Healthcare NHS Trust London UK
2 shared publications
Latest Publications
- 8 September 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (6) , 1440-1447
Gender‐Affirming Laryngeal Surgery: The Effects of the Modified Wendler's Glottoplasty on Voice Pitch and Quality of Life
Objective: To describe the effects of the Modified Wendler's Glottoplasty (MWG) technique on voice pitch and quality of life (QoL) using preoperative and postoperative outcome measures. Study Design: Single institution retrospective review. Setting: Tertiary care private healthcare facility. Methods: A retrospective cohort study was performed of all transgender patients undergoing voice feminisation surgery using the MWG technique by a single surgeon from September 2020 to August 2024. Demographic data was extracted in addition to preoperative and postoperative speaking and reading fundamental frequencies ( f 0 ) and Ten Question Voice Handicap Index (VHI‐10) and TransWoman Voice Questionnaire (TWVQ) scores. Results: 300 patients were included in the study with an average age of 36.9 years. Mean preoperative free continuous speech f 0 was 125.3 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 186.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 182.6 Hz ( P < .00034). Mean preoperative reading f 0 was 127.7 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 191.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 187.8 Hz ( P < .0001). Mean VHI‐10 score was 20.32 preoperatively; this significantly reduced to a mean score of 11.53 at 4 months ( P < .0001). Mean TWVQ score was 93.27 preoperatively; this significantly reduced to a mean score of 52.13 at 4 months ( P < .0001). Conclusion: This study provides a comprehensive assessment of the outcomes associated with MWG in transgender women seeking gender‐affirming voice surgery and demonstrates a significant improvement in vocal pitch and voice‐related QoL following surgery.
- 8 September 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (6) , 1440-1447
Gender‐Affirming Laryngeal Surgery: The Effects of the Modified Wendler's Glottoplasty on Voice Pitch and Quality of Life
Objective: To describe the effects of the Modified Wendler's Glottoplasty (MWG) technique on voice pitch and quality of life (QoL) using preoperative and postoperative outcome measures. Study Design: Single institution retrospective review. Setting: Tertiary care private healthcare facility. Methods: A retrospective cohort study was performed of all transgender patients undergoing voice feminisation surgery using the MWG technique by a single surgeon from September 2020 to August 2024. Demographic data was extracted in addition to preoperative and postoperative speaking and reading fundamental frequencies ( f 0 ) and Ten Question Voice Handicap Index (VHI‐10) and TransWoman Voice Questionnaire (TWVQ) scores. Results: 300 patients were included in the study with an average age of 36.9 years. Mean preoperative free continuous speech f 0 was 125.3 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 186.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 182.6 Hz ( P < .00034). Mean preoperative reading f 0 was 127.7 Hz; at 4 weeks, mean f 0 statistically significantly increased from baseline to 191.2 Hz ( P < .0001) and at 4 months, mean f 0 statistically significantly increased from baseline to 187.8 Hz ( P < .0001). Mean VHI‐10 score was 20.32 preoperatively; this significantly reduced to a mean score of 11.53 at 4 months ( P < .0001). Mean TWVQ score was 93.27 preoperatively; this significantly reduced to a mean score of 52.13 at 4 months ( P < .0001). Conclusion: This study provides a comprehensive assessment of the outcomes associated with MWG in transgender women seeking gender‐affirming voice surgery and demonstrates a significant improvement in vocal pitch and voice‐related QoL following surgery.
- 24 February 2025
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 25 (5) , 379-392
Translating premalignant biology to accelerate non-small-cell lung cancer interception
Over the past decade, substantial progress has been made in the development of targeted and immune-based therapies for patients with advanced non-small-cell lung cancer. To further improve outcomes for patients with lung cancer, identifying and intercepting disease at the earliest and most curable stages are crucial next steps. With the recent implementation of low-dose computed tomography scan screening in populations at high risk, there is an emerging unmet need for new diagnostic, prognostic and therapeutic tools to help treat patients suspected of harbouring premalignant lesions and minimally invasive non-small-cell lung cancer. Continued advances in the identification of the earliest drivers of lung carcinogenesis are poised to address these unmet needs. Employing multimodal approaches to chart the temporal and spatial maps of the molecular events driving lung premalignant lesion progression will refine our understanding of early carcinogenesis. Elucidating the molecular drivers of premalignancy is critical to the development of biomarkers to detect those incubating a premalignant lesion, to stratify risk for progression to invasive cancer and to identify novel therapeutic targets to intercept that process. In this Review, we summarize emerging insights into the earliest cellular and molecular events associated with lung squamous and adenocarcinoma carcinogenesis and highlight the growing opportunity for translating these insights into clinical tools for early detection and disease interception to transform the outcomes for those at risk for lung cancer.
- 24 February 2025
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 25 (5) , 379-392
Translating premalignant biology to accelerate non-small-cell lung cancer interception
Over the past decade, substantial progress has been made in the development of targeted and immune-based therapies for patients with advanced non-small-cell lung cancer. To further improve outcomes for patients with lung cancer, identifying and intercepting disease at the earliest and most curable stages are crucial next steps. With the recent implementation of low-dose computed tomography scan screening in populations at high risk, there is an emerging unmet need for new diagnostic, prognostic and therapeutic tools to help treat patients suspected of harbouring premalignant lesions and minimally invasive non-small-cell lung cancer. Continued advances in the identification of the earliest drivers of lung carcinogenesis are poised to address these unmet needs. Employing multimodal approaches to chart the temporal and spatial maps of the molecular events driving lung premalignant lesion progression will refine our understanding of early carcinogenesis. Elucidating the molecular drivers of premalignancy is critical to the development of biomarkers to detect those incubating a premalignant lesion, to stratify risk for progression to invasive cancer and to identify novel therapeutic targets to intercept that process. In this Review, we summarize emerging insights into the earliest cellular and molecular events associated with lung squamous and adenocarcinoma carcinogenesis and highlight the growing opportunity for translating these insights into clinical tools for early detection and disease interception to transform the outcomes for those at risk for lung cancer.
- Open Access
- 29 February 2024
- Published by Elsevier in Molecular Therapy
- Vol. 32 (5) , 1497-1509
Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa
- 29 February 2024
- Published by Elsevier in Molecular Therapy
- Vol. 32 (5) , 1497-1509
Open AccessLentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa
- 20 November 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 47 (2) , 347-350
Assessment of swallow function pre‐ and post‐endoscopic CO2 laser medial arytenoidectomy: a case series
- 20 November 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 47 (2) , 347-350
Assessment of swallow function pre‐ and post‐endoscopic CO2 laser medial arytenoidectomy: a case series
- 27 September 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 47 (1) , 52-60
Suspension laryngoscopy experiences in a tertiary airway service: A prospective study of 150 procedures
Objectives: In most cases, suspension laryngoscopy (SL) is efficient, bloodless and with minimal post‐procedure discomfort. We aimed to identify predictive patient factors for acceptable surgical views at SL as well as quantify our tertiary airway unit's complication rates.Design: Prospective cohort study of 150 consecutive microlaryngoscopy procedures involving SL over an 8‐month period between November 2019 and July 2020. Patients were assessed preoperatively for pre‐existing oral, temporomandibular, dental, pharyngeal or laryngeal pathology, interincisor distance and qualitative gross limitations to neck extension and forward head posture. Intraoperatively, the laryngoscopic view was graded by anaesthetic and surgical teams, and complications were recorded on patient interview in recovery.Setting: Tertiary adult airway service for predominantly benign pathology.Results: Adequate surgical views were obtained in 149/150 procedures. BMI had a weak positive correlation with a more difficult view (r = .22, p = .008) but did not correlate with a statistically significant increase in any complication. There was a weak negative correlation between age and interincisor gap (r = −.20, p = .014), and wider mouth opening correlated very weakly with a lower incidence of sore throat (r = −.19, p = .023). Gross macroglossia showed a significant moderate positive correlation with tongue symptoms (r = .45, p = 1.611 × 10−8).Conclusion: In the context of an experienced airway unit with a high caseload of predominantly benign pathology, SL is very effective and safe with low associated morbidity and no mortality. The most common complication of SL is temporary sore throat and there remain recognised risks of temporary tongue and dental symptoms.
- 27 September 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 47 (1) , 52-60
Suspension laryngoscopy experiences in a tertiary airway service: A prospective study of 150 procedures
Objectives: In most cases, suspension laryngoscopy (SL) is efficient, bloodless and with minimal post‐procedure discomfort. We aimed to identify predictive patient factors for acceptable surgical views at SL as well as quantify our tertiary airway unit's complication rates.Design: Prospective cohort study of 150 consecutive microlaryngoscopy procedures involving SL over an 8‐month period between November 2019 and July 2020. Patients were assessed preoperatively for pre‐existing oral, temporomandibular, dental, pharyngeal or laryngeal pathology, interincisor distance and qualitative gross limitations to neck extension and forward head posture. Intraoperatively, the laryngoscopic view was graded by anaesthetic and surgical teams, and complications were recorded on patient interview in recovery.Setting: Tertiary adult airway service for predominantly benign pathology.Results: Adequate surgical views were obtained in 149/150 procedures. BMI had a weak positive correlation with a more difficult view (r = .22, p = .008) but did not correlate with a statistically significant increase in any complication. There was a weak negative correlation between age and interincisor gap (r = −.20, p = .014), and wider mouth opening correlated very weakly with a lower incidence of sore throat (r = −.19, p = .023). Gross macroglossia showed a significant moderate positive correlation with tongue symptoms (r = .45, p = 1.611 × 10−8).Conclusion: In the context of an experienced airway unit with a high caseload of predominantly benign pathology, SL is very effective and safe with low associated morbidity and no mortality. The most common complication of SL is temporary sore throat and there remain recognised risks of temporary tongue and dental symptoms.
- Open Access
- 29 May 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (5) , 935-940
Sarcoidosis of the ear, nose and throat: A review of the literature
Objectives: Sarcoidosis is a multisystemic inflammatory disease with extrathoracic manifestations, most commonly affecting the young and middle‐aged, female and Black populations. Diagnosis usually requires evidence of non‐caseating granulomata and, when treated, prognosis is usually favourable. We aim to establish the incidence, clinical features and optimal treatment of ENT manifestations of this disease.Design: We performed a PubMed literature review to determine the evidence base supporting this.Results: ENT manifestations are present in 5%‐15% of patients with sarcoidosis, often as a presenting feature, and require vigilance for swift recognition and coordinated additional treatment specific to the organ. Laryngeal sarcoidosis presents with difficulty in breathing, dysphonia and cough, and may be treated by speech and language therapy (SLT) or intralesional injection, dilatation or tissue reduction. Nasal disease presents with crusting, rhinitis, nasal obstruction and anosmia, usually without sinus involvement. It is treated by topical nasal or intralesional treatments but may also require endoscopic sinus surgery, laser treatment or even nasal reconstruction. Otological disease is uncommon but includes audiovestibular symptoms, both sensorineural and conductive hearing loss, and skin lesions.Conclusions: The consequences of ENT manifestations of sarcoidosis can be uncomfortable, disabling and even life‐threatening. Effective management strategies require good diagnostic skills and use of specific therapies combined with established treatments such as corticosteroids. Comparisons of treatment outcomes are needed to establish best practice in this area.
- 29 May 2021
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (5) , 935-940
Open AccessSarcoidosis of the ear, nose and throat: A review of the literature
Objectives: Sarcoidosis is a multisystemic inflammatory disease with extrathoracic manifestations, most commonly affecting the young and middle‐aged, female and Black populations. Diagnosis usually requires evidence of non‐caseating granulomata and, when treated, prognosis is usually favourable. We aim to establish the incidence, clinical features and optimal treatment of ENT manifestations of this disease.Design: We performed a PubMed literature review to determine the evidence base supporting this.Results: ENT manifestations are present in 5%‐15% of patients with sarcoidosis, often as a presenting feature, and require vigilance for swift recognition and coordinated additional treatment specific to the organ. Laryngeal sarcoidosis presents with difficulty in breathing, dysphonia and cough, and may be treated by speech and language therapy (SLT) or intralesional injection, dilatation or tissue reduction. Nasal disease presents with crusting, rhinitis, nasal obstruction and anosmia, usually without sinus involvement. It is treated by topical nasal or intralesional treatments but may also require endoscopic sinus surgery, laser treatment or even nasal reconstruction. Otological disease is uncommon but includes audiovestibular symptoms, both sensorineural and conductive hearing loss, and skin lesions.Conclusions: The consequences of ENT manifestations of sarcoidosis can be uncomfortable, disabling and even life‐threatening. Effective management strategies require good diagnostic skills and use of specific therapies combined with established treatments such as corticosteroids. Comparisons of treatment outcomes are needed to establish best practice in this area.
- 26 February 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (5) , E1639
In Response to Voice, Swallow and Airway Outcomes Following Tracheostomy for COVID‐19
- 26 February 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (5) , E1639
In Response to Voice, Swallow and Airway Outcomes Following Tracheostomy for COVID‐19
- Open Access
- 20 December 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , E1918-E1925
A Prospective Study of Voice, Swallow, and Airway Outcomes Following Tracheostomy for COVID‐19
Objective: The COVID‐19 pandemic has led to unprecedented demands on healthcare with many requiring intubation. Tracheostomy insertion has often been delayed and the enduring effects of this on voice, swallow, and airway outcomes in COVID‐19 tracheostomy patients are unknown. The aim of this study was to prospectively assess these outcomes in this patient cohort following hospital discharge.Methods: All COVID‐19 patients who had undergone tracheostomy insertion, and were subsequently decannulated, were identified at our institution and followed up 2 months post‐discharge. Patient‐reported (PROMS) and clinician‐reported outcome measures, endoscopic examination, and spirometry were used to assess voice, swallow, and airway outcomes.Results: Forty‐one patients were included in the study with a mean age of 56 years and male:female ratio of 28:13. Average duration of endotracheal intubation was 24 days and 63.4% of tracheostomies were performed at day 21 to 35 of intubation. 53.7% had an abnormal GRBAS score and 30% reported abnormal swallow on EAT‐10 questionnaire. 81.1% had normal endoscopic examination of the larynx, however, positive endoscopic findings correlated with the patient self‐reported VHI‐10 (P = .036) and EAT‐10 scores (P = .027). 22.5% had spirometric evidence of fixed upper airway obstruction using the Expiratory‐Disproportion Index (EDI) and Spearman correlation analysis showed a positive trend between abnormal endoscopic findings and EDI scores over 50 (P < .0001).Conclusion: The preliminary results of this study reveal a high incidence of laryngeal injury among patients who underwent intubation and tracheostomy insertion during the COVID‐19 pandemic. As these patients continue to be followed up, the evolution of these complications will be studied.Level of Evidence: 3 Laryngoscope, 131:E1918–E1925, 2021
- 20 December 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , E1918-E1925
Open AccessA Prospective Study of Voice, Swallow, and Airway Outcomes Following Tracheostomy for COVID‐19
Objective: The COVID‐19 pandemic has led to unprecedented demands on healthcare with many requiring intubation. Tracheostomy insertion has often been delayed and the enduring effects of this on voice, swallow, and airway outcomes in COVID‐19 tracheostomy patients are unknown. The aim of this study was to prospectively assess these outcomes in this patient cohort following hospital discharge.Methods: All COVID‐19 patients who had undergone tracheostomy insertion, and were subsequently decannulated, were identified at our institution and followed up 2 months post‐discharge. Patient‐reported (PROMS) and clinician‐reported outcome measures, endoscopic examination, and spirometry were used to assess voice, swallow, and airway outcomes.Results: Forty‐one patients were included in the study with a mean age of 56 years and male:female ratio of 28:13. Average duration of endotracheal intubation was 24 days and 63.4% of tracheostomies were performed at day 21 to 35 of intubation. 53.7% had an abnormal GRBAS score and 30% reported abnormal swallow on EAT‐10 questionnaire. 81.1% had normal endoscopic examination of the larynx, however, positive endoscopic findings correlated with the patient self‐reported VHI‐10 (P = .036) and EAT‐10 scores (P = .027). 22.5% had spirometric evidence of fixed upper airway obstruction using the Expiratory‐Disproportion Index (EDI) and Spearman correlation analysis showed a positive trend between abnormal endoscopic findings and EDI scores over 50 (P < .0001).Conclusion: The preliminary results of this study reveal a high incidence of laryngeal injury among patients who underwent intubation and tracheostomy insertion during the COVID‐19 pandemic. As these patients continue to be followed up, the evolution of these complications will be studied.Level of Evidence: 3 Laryngoscope, 131:E1918–E1925, 2021
- 29 April 2018
- Published by Wiley in Clinical Otolaryngology
- Vol. 43 (5) , 1201-1208
Role of local anaesthetic nerve block in endoscopic sinus surgery: A systematic review and meta‐analysis
Objective: The aim of the study was to perform a systematic review of existing evidence on the role of local anaesthetic nerve block (LAB) in patients undergoing endoscopic sinus surgery (ESS).Design: The databases searched were the Cochrane Register of Controlled Trials, MEDLINE and Embase using the Ovid portal (1946‐2017).Results: Seven randomised controlled trials were included. Due to considerable heterogeneity of data, only two studies were pooled into meta‐analysis which demonstrated a statistically significantly better surgical field quality during ESS in the LAB group compared with the control group (MD −0.86; 95% CI −2.24, 0.51; P = .009). No adverse events related to LAB toxicity were reported.Conclusions: Sphenopalatine ganglion LAB with adrenaline carries relatively low risk of morbidity, but may improve the quality of the surgical field in terms of bleeding. However, there are limitations of the study due to heterogeneity of methods, quality and size of the studies. Well‐conducted large RCTs are needed using standardised inclusion criteria, balanced baseline characteristics of cohorts, and validated subjective and objective outcome measures.
- 29 April 2018
- Published by Wiley in Clinical Otolaryngology
- Vol. 43 (5) , 1201-1208
Role of local anaesthetic nerve block in endoscopic sinus surgery: A systematic review and meta‐analysis
Objective: The aim of the study was to perform a systematic review of existing evidence on the role of local anaesthetic nerve block (LAB) in patients undergoing endoscopic sinus surgery (ESS).Design: The databases searched were the Cochrane Register of Controlled Trials, MEDLINE and Embase using the Ovid portal (1946‐2017).Results: Seven randomised controlled trials were included. Due to considerable heterogeneity of data, only two studies were pooled into meta‐analysis which demonstrated a statistically significantly better surgical field quality during ESS in the LAB group compared with the control group (MD −0.86; 95% CI −2.24, 0.51; P = .009). No adverse events related to LAB toxicity were reported.Conclusions: Sphenopalatine ganglion LAB with adrenaline carries relatively low risk of morbidity, but may improve the quality of the surgical field in terms of bleeding. However, there are limitations of the study due to heterogeneity of methods, quality and size of the studies. Well‐conducted large RCTs are needed using standardised inclusion criteria, balanced baseline characteristics of cohorts, and validated subjective and objective outcome measures.
- Open Access
- 29 January 2018
- Published by SAGE Publications in Journal of the Intensive Care Society
- Vol. 19 (4) , 351-353
Leptospirosis presenting as severe cardiogenic shock: A case report
Background: Leptospirosis is a rare infectious illness caused by the Spirochaete Leptospira. It has a wide-varying spectrum of presentation. We present a rare case of severe cardiogenic shock secondary to leptospirosis, in the absence of its common clinical features. Case presentation: A 36-year-old woman presented to our unit with severe cardiogenic shock and subsequent multi-organ failure. Her clinical course was characterised by ongoing pyrexia of unknown origin with concurrent cardiac failure. She was initially managed with broad-spectrum antibiotics and inotropes. Percutaneous cardiac biopsy excluded major causes of myocarditis. On day 21 after presentation, she was found to be IgM-positive for leptospirosis. Conclusions: This is a rare case of severe cardiogenic shock secondary to leptospirosis infection. The case also highlights the importance of obtaining a thorough social history when assessing a patient with an unusual presentation, as clues can often be missed.
- 29 January 2018
- Published by SAGE Publications in Journal of the Intensive Care Society
- Vol. 19 (4) , 351-353
Open AccessLeptospirosis presenting as severe cardiogenic shock: A case report
Background: Leptospirosis is a rare infectious illness caused by the Spirochaete Leptospira. It has a wide-varying spectrum of presentation. We present a rare case of severe cardiogenic shock secondary to leptospirosis, in the absence of its common clinical features. Case presentation: A 36-year-old woman presented to our unit with severe cardiogenic shock and subsequent multi-organ failure. Her clinical course was characterised by ongoing pyrexia of unknown origin with concurrent cardiac failure. She was initially managed with broad-spectrum antibiotics and inotropes. Percutaneous cardiac biopsy excluded major causes of myocarditis. On day 21 after presentation, she was found to be IgM-positive for leptospirosis. Conclusions: This is a rare case of severe cardiogenic shock secondary to leptospirosis infection. The case also highlights the importance of obtaining a thorough social history when assessing a patient with an unusual presentation, as clues can often be missed.